Pharma Journalist 7836 posts 0 comments

Marinus Pharmaceuticals presented preclinical data showing that the combination of its CNS-selective GABAA modulator ganaxolone and diazepam administered intravenously (IV) produced a…
Read More...

PAREXEL International has launched an Identification of Medicinal Products (IDMP)-focused solution for biopharmaceutical companies. LIQUENT InSight for IDMP is the newest module…
Read More...

A new whitepaper from business intelligence provider GBI Research - The Emerging Field of Cannabinoid-Based Products - states that despite legal restrictions limiting research into the…
Read More...

UK artificial intelligence (AI) firm BenevolentAI has signed an exclusive license for a series of novel clinical stage drug candidates with Janssen Pharmaceutica (Janssen), one of the…
Read More...

DNAtrix, a clinical stage biotechnology company developing virus-driven immunotherapies for cancer, announced it has entered into an exclusive license agreement with the University of…
Read More...

The international technology group Körber, headquartered in Hamburg, Germany, is planning to acquire the company Fargo Automation, Inc., based in Fargo, North Dakota, USA. Fargo…
Read More...

ERS Genomics and Knudra Transgenics have signed a non-exclusive license agreement on CRISPR-Cas9 genome editing patents for model organisms. The deal provides Knudra with worldwide…
Read More...

DNAtrix, a clinical stage biotechnology company developing virus-driven immunotherapies for cancer, announced that the first patients have been treated in a multicenter Phase 2 trial…
Read More...

Portola Pharmaceuticals (PTLA) has expanded its existing clinical collaboration agreement with Daiichi Sankyo to develop AndexXa (andexanet alfa) as an antidote for the former’s Factor…
Read More...

Nimbus Therapeutics secured a $200m from Gilead Sciences in a payment related to the latter’s allosteric Acetyl-CoA Carboxylase (ACC) inhibitor program with NDI-010976 (now GS-0976)…
Read More...